Special section: Replication stress, a threat to the nuclear and mitochondrial genome Dysfunction of chromosomal DNA repair was recognized as disease mechanism in the sixties, when nucleotide excision repair defects were identified as the cause of Xeroderma pigmentosum [1] . In the seventies the key mechanisms to ensure discontinued DNA replication past a lesion were discovered: (i) switching between the parental strands involving the Bloom syndrome and Fanconi anemia (Fanc) complementation group proteins to bypass an interstrand DNA crosslink [2] and (ii) direct DNA synthesis across DNA lesions via specialized translesion synthesis (TLS) polymerases. In the nineties polymerase η defects were connected with Xeroderma pigmentosum variant [3] . Since then the list of Fanc proteins, TLS polymerases, RecQ helicases and other disease-associated factors involved in replication fork recovery has been growing. Even for breast cancer susceptibility genes like BRCA2 pathogenic mutations causing replication fork protection without affecting classical disease-related functions in homologous recombination were described [4] .
system and increased incidence of myeloproliferative diseases including hematopoietic malignancies. Direct evidence of a causal relationship between replication stress and premature aging in HSCs was recently provided by a mouse model inactivating the PCNA switchboard [11] . However, even though extremely valuable, simple extrapolation of mouse data to human systems is dangerous due to the significant differences that have been observed in HSC biology and DNA damage responses between the two species. While data sets on natural aging in human individuals are still rare, valuable information was retrieved from patients with premature aging syndromes, i.e. progerias.
Several progerias are caused by hereditary mutations in genes with functions in DNA replication fork protection such as Bloom syndrome, Rothmund-Thompson syndrome, Werner syndrome and Fanconi anemia [12] . All of them affect stem cell compartments. Fanconi anemia patients show features of the normal aging process of HSCs with bone marrow failure, genomic instability and leukemia proneness. Failure to resolve replication damage has been exploited for diagnostic purposes via ex vivo exposure of patient cells to interstrand DNA crosslinking agents like Mitomycin C. These treatments mimic endogenous crosslinking processes e.g. at abasic sites generated by spontaneous hydrolysis or the action of a DNA glycosylase [13] . Frederico et al. [14] provide insight into the activities of FancD2 in replication fork protection and replication-coupled DNA repair activities. FancD2 is particular in that it represents a central node of the Fanconi anemia repair pathway and exerts critical functions independently of the core Fanc protein complex. In the early phase of the replication damage response FancD2 coordinates engagement of TLS and homologous recombination in concert with PCNA. At later stages it controls DSB repair pathway usage at collapsed forks ensuring high fidelity repair by homologous recombination rather than non-homologous end joining. Together with the Bloom syndrome product BLM, FancD2 protects hard-toreplicate regions like CFSs from persistent replication stress. At these sites it promotes not only DNA replication progression but also termination. Failure leads to the formation of ultrafine chromosome bridges labeling unresolved connections between chromatids in anaphase. FancD2 therefore also ensures proper chromosome segregation and prevents transmission of replication damage to daughter cells.
Mitochondria make use of nuclear-encoded DNA replication proteins, and even FancD2 was found to play a role in mitochondria, namely in ATP production [15] . Notably, perturbations of DNA replication both in the nucleus and in mitochondria have been associated with organismal aging [16] . However, many details of DNA replication in mitochondria have remained enigmatic. In this Special Section Ricchetti [17] summarizes our current knowledge of replication stress in mitochondria. Despite the shared use of enzymes and links with aging and diseases, there are significant differences between DNA replication in mitochondria as compared with the nucleus, due to an orders of magnitude (i) smaller size and (ii) higher copy number of the genome, (iii) its circular organization and dense packing with coding sequences, (iv) a distinct mechanism with asymmetry between leading and lagging strand synthesis generating intermediates with a long stretch of single-stranded DNA. Despite all these differences replication stress arises in both organelles after perturbation of the nucleotide pool, the replication machinery or the DNA template such as by oxidative DNA damage. In recent years powerful methods to study mitochondrial DNA replication have been developed such as mTRIP, which relies on fluorescence in situ hybridization of the active replication origin [18] and single molecule fiber analysis detecting nascent mitochondrial DNA synthesis [19] . Mitochondrial replication stalling may cause slippage between direct repeats and result in a DNA deletion. Mutations causing DNA replication failure such as in the nuclear gene encoding polymerase γ are associated with diseases characterized by premature aging or neurological decline and promote aerobic glycolysis in cancer cells [20] . Much remains to be learnt about the coordination of mitochondrial and nuclear replication processes and signaling in response to replication stress. Another challenge will be to understand the communication between heterogeneous mitochondria within the same cell, which can neutralize detrimental effects of mutations by sharing and exchanging genetic material by fusion and fission processes or mitophagy.
With the availability of new and powerful methods we have begun to grasp the critical role of nuclear and mitochondrial DNA replication stress in natural aging and disease mechanisms. Stunningly, after decades of effective use of replication stress-inducing cytostatics, only now we realize the great potential of drugs manipulating these processes.
